UNSPSC 51122801: Almokalant

This classification denotes a cation channel blocker and antiarrhythmic agent with the molecular formula C18H28N2O3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) I9NG89L275, chemically known as benzonitrile, 4-(3-(ethyl(3-(propylsulfinyl)propyl)amino)-2-hydroxypropoxy)- but more generally known as almokalant, which bears US NIH Compound Identifier 3033962. European Medicines Agency schedules Almokalant in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05349MIG.

UNSPSC 51122801 Almokalant, a Commodity-tier code, covers emergency medical medications supplied to state and local fire rescue and emergency medical services — specifically advanced life support agents such as epinephrine, labetalol, adenosine, and diltiazem. The code captures procurement of individual medication line items measured in units (vials, injections) with firm expiration-date requirements and rapid delivery windows typical of emergency medical supply chains. Issuing bodies soliciting under this code include city fire departments and municipal emergency services offices that stock and rotate emergency pharmaceuticals for field paramedic use.

The City of Tampa's Purchasing Department issued an IFB (Bid No. 26-P-00188) in April 2026 for Advanced Life Support Medications to supply Tampa Fire Rescue across Hillsborough County, Florida, with an estimated contract value of $40,000.00 and response deadline of April 8, 2026. The solicitation required four specific medication line items totaling approximately 3,530 units, with nine-month-minimum expiration dates, ten-calendar-day delivery, one-year firm terms renewable twice at the city's option, and an SLBE sheltered-market set-aside offering a 5 percent bid discount not to exceed $10,000.00. The source identifies no additional recent opportunities under the code.